Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyIOL CHEMICALS & PHARMACEUTICALS LTD. 2CIN NO.L24116PB1986PLC007030 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Abhay Raj Singh Designation: Vice President and Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Pardeep Kumar Khanna Designation: Chief Financial Officer EmailId: [email protected] Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31st March 2023
25-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Notice Of The Board Meeting

IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the Quarter and year ended 31st March 2023
21-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification On Price Movement

With reference to your mail Ref No. L/SURV/ONL/PV/MG/ 2023-2024 / 3272 dated 20th April 2023, we wish to submit that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. We would like to further inform and clarify that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
21-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification sought from IOL Chemicals & Pharmaceuticals Ltd

The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on April 20, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
21-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Certificate Under Clause 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Clause 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a certificate received from Practicing Company Secretary for the year ended 31st March 2023.
19-04-2023
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement confirming dispatch of Postal Ballot Notice
12-04-2023
Next Page
Close

Let's Open Free Demat Account